<?xml version="1.0" encoding="UTF-8"?>
<ref id="R32">
 <label>32</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Rao</surname>
    <given-names>M</given-names>
   </name>, 
   <name name-style="western">
    <surname>Valentini</surname>
    <given-names>D</given-names>
   </name>, 
   <name name-style="western">
    <surname>Dodoo</surname>
    <given-names>E</given-names>
   </name>, 
   <etal>et al</etal>
  </person-group>
  <article-title>Anti-Pd-1/Pd-L1 therapy for infectious diseases: learning from the cancer paradigm</article-title>. 
  <source>Int J Infect Dis</source>
  <year>2017</year>;
  <volume>56</volume>:
  <fpage>221</fpage>–
  <lpage>8</lpage>. 
  <comment>‐</comment>. 
  <pub-id pub-id-type="doi">10.1016/j.ijid.2017.01.028</pub-id>
  <?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/28163164?>
  <pub-id pub-id-type="pmid">28163164</pub-id>
 </mixed-citation>
</ref>
